Safety Study of Anti-IgE Immunotherapy in Allergic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00439621
Recruitment Status : Completed
First Posted : February 23, 2007
Last Update Posted : August 18, 2008
Information provided by:
Resistentia Pharmaceuticals AB

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2008
  Actual Study Completion Date : August 2008